On November 6, 2025, President Trump announced agreements with pharmaceutical manufacturers Eli Lilly and Novo Nordisk to dramatically reduce GLP-1 prices and expand Medicare coverage for obesity
Its used strategically, never on its own, and always as part of a broader clinical program
It is the same mechanism that makes pyridoxine effective for pregnancy nausea, chemotherapy-induced nausea, and motion sickness
Safe use still means clinician-guided dosing and quality-controlled products
adults with overweight or obesity
Popular options and their typical goals include: CJC-1295 / Ipamorelin: Signals the pituitary to support growth hormone pulsatilityused in programs targeting body composition , recovery , and sleep quality